Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prem L Sharma

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Virology|April 5, 2011
Reverse transcriptase mutation K65N confers a decreased replication capacity to HIV-1 in comparison to K65R due to a decreased RT processivityHimaBindu Chunduri, Clyde Crumpacker, Prem L Sharma
Antiviral Chemistry & Chemotherapy|July 12, 2005
Retrovirus reverse transcriptases containing a modified YXDD motifPrem L Sharma, Viktoria Nurpeisov, Raymond F Schinazi
Journal of Clinical Microbiology|July 5, 2003
Fluorescent dye terminator sequencing methods for quantitative determination of replication fitness of human immunodeficiency virus type 1 containing the codon 74 and 184 mutations in reverse transcriptaseViktoria Nurpeisov, Selwyn J Hurwitz, Prem L Sharma
Viral Immunology|January 14, 2012
Replication-independent expression of anti-apoptosis marker genes in human peripheral blood mononuclear cells infected with the wild-type HIV-1 and reverse transcriptase variantsPrem L Sharma, Himabindu Chunduri, Jasen Wise, et al.
Virology Journal|January 25, 2011
A Leu to Ile but not Leu to Val change at HIV-1 reverse transcriptase codon 74 in the background of K65R mutation leads to an increased processivity of K65R+L74I enzyme and a replication competent virusHimabindu Chunduri, David Rimland, Viktoria Nurpeisov, et al.
Antiviral Research|June 27, 2009
Comparative analysis of in vitro processivity of HIV-1 reverse transcriptases containing mutations 65R, 74V, 184V and 65R+74VPrem L Sharma, James H Nettles, Anya Feldman, et al.
Current Topics in Medicinal Chemistry|May 12, 2004
Nucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptasePrem L Sharma, Viktoria Nurpeisov, Brenda Hernandez-Santiago, et al.
Virology|March 31, 2004
Replication-dependent 65R-->K reversion in human immunodeficiency virus type 1 reverse transcriptase double mutant K65R + L74VPrem L Sharma, Viktoria Nurpeisov, Kimberly Lee, et al.
Antimicrobial Agents and Chemotherapy|July 29, 2005
Quantifying mixed populations of drug-resistant human immunodeficiency virus type 1Michael J Moser, Meta Ruckstuhl, Christine A Larsen, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Virology|April 5, 2011
Reverse transcriptase mutation K65N confers a decreased replication capacity to HIV-1 in comparison to K65R due to a decreased RT processivityHimaBindu Chunduri, Clyde Crumpacker, Prem L Sharma
Antiviral Chemistry & Chemotherapy|July 12, 2005
Retrovirus reverse transcriptases containing a modified YXDD motifPrem L Sharma, Viktoria Nurpeisov, Raymond F Schinazi
Journal of Clinical Microbiology|July 5, 2003
Fluorescent dye terminator sequencing methods for quantitative determination of replication fitness of human immunodeficiency virus type 1 containing the codon 74 and 184 mutations in reverse transcriptaseViktoria Nurpeisov, Selwyn J Hurwitz, Prem L Sharma
Viral Immunology|January 14, 2012
Replication-independent expression of anti-apoptosis marker genes in human peripheral blood mononuclear cells infected with the wild-type HIV-1 and reverse transcriptase variantsPrem L Sharma, Himabindu Chunduri, Jasen Wise, et al.
Virology Journal|January 25, 2011
A Leu to Ile but not Leu to Val change at HIV-1 reverse transcriptase codon 74 in the background of K65R mutation leads to an increased processivity of K65R+L74I enzyme and a replication competent virusHimabindu Chunduri, David Rimland, Viktoria Nurpeisov, et al.
Antiviral Research|June 27, 2009
Comparative analysis of in vitro processivity of HIV-1 reverse transcriptases containing mutations 65R, 74V, 184V and 65R+74VPrem L Sharma, James H Nettles, Anya Feldman, et al.
Current Topics in Medicinal Chemistry|May 12, 2004
Nucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptasePrem L Sharma, Viktoria Nurpeisov, Brenda Hernandez-Santiago, et al.
Virology|March 31, 2004
Replication-dependent 65R-->K reversion in human immunodeficiency virus type 1 reverse transcriptase double mutant K65R + L74VPrem L Sharma, Viktoria Nurpeisov, Kimberly Lee, et al.
Antimicrobial Agents and Chemotherapy|July 29, 2005
Quantifying mixed populations of drug-resistant human immunodeficiency virus type 1Michael J Moser, Meta Ruckstuhl, Christine A Larsen, et al.
Pageof 1